We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.
MSK Oncology Educational Atlas 图标

1.0.0 by The University of Michigan


2018年04月23日

关于MSK Oncology Educational Atlas

互动教育肿瘤骨科阿特拉斯从大学。密歇根

Orthopaedic surgery residents often struggle to identify time-saving study resources to prepare for board and in-service examinations. To address this concern, the University of Michigan Department of Orthopaedic Surgery developed this interactive educational tool focusing on the most common and testable topics related to Orthopaedic Oncology. This app highlights the important aspects of Benign and Malignant Bone and Soft Tissue Tumors with emphasis on radiographic and histological characteristics with appropriate and up-to-date treatment options. Self-assessment multiple choice questions are included to aid in exam preparation.

45 self-paced content modules, and electronic self-assessments:

Lesson List

Primary Malignant Bone

-Osteosarcoma (6 modules)

-Ewing Sarcoma (1 module)

-Chondrosarcoma (3 modules)

Benign Bone

-Chondroid (4 modules)

-Cysts (2 modules)

-Fibrous (2 modules)

Soft Tissue Benign

-Fibrous (3 modules)

-Lymphovascular (2 modules)

-Intra-articular (2 modules)

-Neurogenic (2 modules)

-Miscellaneous (3 modules)

Soft Tissue Sarcoma

-Overview of Soft Tissue Sarcoma (1 module)

-Rhabdomyosarcoma Variants (3 modules)

-Liposarcoma Variants (3 modules)

-Nervous System Variants (1 module)

-Other Variants (5 modules)

Metastatic Bone

-Metastatic Disease (1 module)

最新版本1.0.0更新日志

Last updated on 2018年04月23日

Minor bug fixes and improvements. Install or update to the newest version to check it out!

翻译中...

更多应用信息

最新版本

请求 MSK Oncology Educational Atlas 更新 1.0.0

上传者

Ajay A Waghela

系统要求

Android 5.0+

更多

MSK Oncology Educational Atlas 屏幕截图

订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
订阅成功!
您已订阅APKPure。
订阅APKPure
第一时间获取热门安卓游戏应用的首发体验,最新资讯和玩法教程。
不,谢谢
订阅
成功!
您已订阅我们的邮件通知。